Cargando…
THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
Disclosure: C. Ufondu: None. L. Clem: None. M. Musick: None. M.J. Sikora: None. J.H. Ostrander: None. Invasive lobular carcinoma (ILC) is an estrogen-receptor (ER)-positive histologic subtype of breast cancer typically treated with anti-estrogens (i.e., tamoxifen and aromatase inhibitors). Anti-estr...
Autores principales: | Ufondu, Chinasa, Clem, Larkin, Musick, Maggie, Sikora, Matthew Joseph, Ostrander, Julie Hanson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553685/ http://dx.doi.org/10.1210/jendso/bvad114.2105 |
Ejemplares similares
-
THU552 Understanding Radiation Therapy Sensitivity In Invasive Lobular Carcinoma Of The Breast
por: Boysen, Michael Rhinehart, et al.
Publicado: (2023) -
THU556 Targeting Breast Cancer Stem Cells With Oncolytic Virus
por: Roman Ortiz, Natasha Ivelisse, et al.
Publicado: (2023) -
THU495 Glutamate Metabolic Enzymes GLUD1/2 And GPX4 Are Associated with Tumor Size In Black Women With Invasive Lobular Breast Cancer
por: Young, Todd, et al.
Publicado: (2023) -
THU554 Unconventional Estrogen Receptor Antagonists Reveal Cryptic Therapeutic Anti-breast Cancer Transcriptional Pathways
por: Hancock, Govinda, et al.
Publicado: (2023) -
THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)